Literature DB >> 15152631

Monoclonal antibodies market.

Janice Reichert, Alex Pavolu.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15152631     DOI： 10.1038/nrd1386

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  20 in total

1.  In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations.

Authors:  Pirouz Daftarian; Raquibul Chowdhury; Philip Ames; Changli Wei; Alan D King; Juan Pablo de Rivero Vaccari; Lloye Dillon; Justin Price; Howard Leung; Brittany Ashlock; Enrique Mesri; Victor Perez; Stephan Züchner; Jochen Reiser; Vance Lemmon; Robert W Keane
Journal:  Hybridoma (Larchmt)       Date:  2011-10

2.  Equipment characterization to mitigate risks during transfers of cell culture manufacturing processes.

Authors:  Christian Sieblist; Marco Jenzsch; Michael Pohlscheidt
Journal:  Cytotechnology       Date:  2015-08-01       Impact factor: 2.058

Review 3.  New concepts in antibody-mediated immunity.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Production of recombinant antitumor antibodies by HEK-293 cells.

Authors:  S M Deyev; O A Stremovskiy; S V Lukash; D V Karpenko; O L Polyanovsky; R V Petrov
Journal:  Dokl Biochem Biophys       Date:  2006 Jan-Feb       Impact factor: 0.788

5.  Introduction to animal cell culture technology-past, present and future.

Authors:  O-W Merten
Journal:  Cytotechnology       Date:  2006-08-03       Impact factor: 2.058

6.  Probabilities of success for antibody therapeutics.

Authors:  Janice M Reichert
Journal:  MAbs       Date:  2009-07-18       Impact factor: 5.857

7.  Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates.

Authors:  Steven A Jacobs; Sheng-Jiun Wu; Yiqing Feng; Deidra Bethea; Karyn T O'Neil
Journal:  Pharm Res       Date:  2009-11-13       Impact factor: 4.200

Review 8.  Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view.

Authors:  C Andrew Boswell; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2007-06-08       Impact factor: 2.408

9.  Use of pharmacokinetic/ pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics.

Authors:  Balaji M Agoram
Journal:  Br J Clin Pharmacol       Date:  2008-12-11       Impact factor: 4.335

10.  SnugDock: paratope structural optimization during antibody-antigen docking compensates for errors in antibody homology models.

Authors:  Aroop Sircar; Jeffrey J Gray
Journal:  PLoS Comput Biol       Date:  2010-01-22       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.